Kelly Bertram

Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial

Günter U. Höglinger, Irene Litvan, Nuno Mendonça et al. · The Lancet Neurology · 2021 · 138 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +4

Sex differences in Parkinson’s disease

Michal Lubomski, R. Louise Rushworth, Will Lee et al. · Journal of Clinical Neuroscience · 2014 · 97 citations

Life Sciences, Neurology, Neuroscience +14

Influence of Single Nucleotide Polymorphisms in <b><i>COMT</i></b>, <b><i>MAO-A</i></b> and <b><i>BDNF</i></b> Genes on Dyskinesias and Levodopa Use in Parkinson's Disease

Perdita Cheshire, Kelly Bertram, Helen Ling et al. · Neurodegenerative Diseases · 2013 · 66 citations · Full text

Life Sciences, Genetics, Neurology +16

Short and Long Term Outcome of Bilateral Pallidal Stimulation in Chorea-Acanthocytosis

Marie Miquel, Umberto Spampinato, Chrystelle Latxague et al. · PLoS ONE · 2013 · 56 citations · Full text

Medicine, Neurology, Surgery +17

Serotonergic markers in Parkinson's disease and levodopa‐induced dyskinesias

Perdita Cheshire, Scott Ayton, Kelly Bertram et al. · Movement Disorders · 2015 · 45 citations · Full text

Life Sciences, Neurology, Neuroscience +17